Onlymyhealth on MSN
Is Your Baby at Risk? Why Rare Blood Group Incompatibility Causes Severe Newborn Anaemia
Welcoming a newborn is usually a time of pure joy for any family, but for some parents, unexpected health scares like severe ...
US President Donald Trump says the strikes on Iran were meant to eliminate a threat, but how he expects the conflict to end ...
Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) and ...
Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate. | Disc Medicine is laying off a fifth of its workforce as the ...
Senate Bill 78, approved 36-12, would require students to leave phones and smartwatches at home or put them in a secure ...
A new effort to dismiss charges against a driver accused of killing NHL star Johnny Gaudreau and his brother is based on the ...
Tranekær S, Hansen DL, Frederiksen H. Epidemiology of secondary warm autoimmune haemolytic anaemia-A systematic review and meta-analysis. J Clin Med . 2021 ...
The donated blood on the shelves is what is utilized in an emergency, so the dedication to donating regularly is vital for patients getting the blood they need,” she said. “Gene’s donations alone ...
Pursuing a traditional approval path for bitopertin in erythropoietic protoporphyria (EPP); Phase 3 APOLLO study is expected to complete enrollment in March 2026 with topline data expected in Q4 ...
A years-long battle between a celebrated hydrologist and a respected environmental juggernaut led to accusations about political motivations and stealing trade secrets ...
Trump announced new measures aimed at safeguarding maritime trade and energy shipments through the Gulf, saying the United States would ensure the “free flow of energy to the world.” ...
PYRUKYND is also approved for adults with PK deficiency in the U.S. and Europe, and a marketing application for PYRUKYND in thalassemia is currently under review by the European Commission. In the U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results